| 88.34 -6.59 (-6.94%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 117.75 |
1-year : | 127.89 |
| Resists | First : | 100.81 |
Second : | 109.5 |
| Pivot price | 97.43 |
|||
| Supports | First : | 86.76 |
Second : | 72.19 |
| MAs | MA(5) : | 95.95 |
MA(20) : | 98.52 |
| MA(100) : | 102.51 |
MA(250) : | 100.45 |
|
| MACD | MACD : | -1 |
Signal : | 0 |
| %K %D | K(14,3) : | 24 |
D(3) : | 37.5 |
| RSI | RSI(14): 35.7 |
|||
| 52-week | High : | 124.11 | Low : | 70.23 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ IRTC ] has closed below the lower bollinger band by 14.0%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ IRTC ] is to continue within current trading range. Bollinger Bands are 15.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 95.74 - 96.32 | 96.32 - 96.75 |
| Low: | 85.49 - 86.2 | 86.2 - 86.73 |
| Close: | 87.4 - 88.46 | 88.46 - 89.24 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Fri, 26 Jul 2024
iRhythm Technologies (NASDAQ:IRTC) Shares Down 6.2% - MarketBeat
Thu, 25 Jul 2024
iRhythm Technologies (IRTC) Set to Announce Earnings on Thursday - Defense World
Tue, 23 Jul 2024
iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Average Rating of "Buy" by Brokerages - MarketBeat
Sat, 20 Jul 2024
Swiss National Bank Purchases 200 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
Thu, 18 Jul 2024
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024 - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 31 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 113.4 (%) |
| Shares Short | 2,880 (K) |
| Shares Short P.Month | 2,870 (K) |
| EPS | -4.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.9 |
| Profit Margin | -25.4 % |
| Operating Margin | -29 % |
| Return on Assets (ttm) | -9.1 % |
| Return on Equity (ttm) | -83.3 % |
| Qtrly Rev. Growth | 18.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 16.5 |
| EBITDA (p.s.) | -2.97 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -71 (M) |
| Levered Free Cash Flow | -29 (M) |
| PE Ratio | -20.94 |
| PEG Ratio | 0 |
| Price to Book value | 30.46 |
| Price to Sales | 5.35 |
| Price to Cash Flow | -38.49 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|